Skip to content

Trendelenburg Maneuver Predicts Fluid Responsiveness in Patients With Extracorporeal Membrane Oxygenation (TEMPLE)

Hemodynamic Changes Induced by Trendelenburg Maneuver to Predict Fluid Responsiveness in Patients With Extracorporeal Membrane Oxygenation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03553459
Enrollment
40
Registered
2018-06-12
Start date
2018-07-01
Completion date
2022-12-30
Last updated
2019-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporeal Membrane Oxygenation

Keywords

fluid responsiveness, trendelenburg, extracorporeal membrane oxygenation

Brief summary

The purpose of the study is to verify the efficacy of using trendelenburg maneuver to predict fluid responsiveness in patients with extracorporeal membrane oxygenation

Interventions

DIAGNOSTIC_TESTTrendelenburg Maneuver

In the Trendelenburg position, the body is laid supine, or flat on the back with the feet higher than the head by 15-30 degrees. The venous return increases in the trendelenburg position which in turn increases the stroke volume.

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients with ECMO and mechanical ventilator support * hypotension (MAP\<65mmHg) * required volume expansion by clinical judgement of the intensivists

Exclusion criteria

* severe hypotension with high dose of vasopressors * severe valve regurgitation * cardiac arrhythmia

Design outcomes

Primary

MeasureTime frameDescription
responderswithin 1 minute after volume expansionresponders are defined by stroke volume increases over 15% after volume expansion of 500ml crystalloid
nonresponderswithin 1 minute after volume expansionnonresponders are defined by stroke volume increases less than 15% after volume expansion of 500ml crystalloid

Countries

China

Contacts

Primary ContactGuo-wei Tu, Doctor
tu.guowei@zs-hospital.sh.cn86-021-64041990

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026